High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
The idea makes more than enough sense. Not every idea, however, has an easily identifiable way of capitalizing on it.
CoreWeave's AI platform, giant backlog, and gigawatt-scale build-out make a compelling case for long-term stock gains.
The company could raise up to $5.5 billion, with another $500 million available through a greenshoe option.
Instead of investing in Anthropic directly, consider an investment in Amazon.
Anthropic is planning to go public soon in a high-profile IPO.
A rule Nasdaq wrote this spring could put the Claude maker in index funds within weeks of its debut. SpaceX just showed how small the slice starts.
The economy may be sputtering, but the luxury travel niche is not.
The tech megacaps have multiple ways to cash in as the foundational AI model giant prepares to join the public market.
Nscale filed for a U.S. initial public offering on September 18 with one number that makes the AI-cloud boom look radioactive: the company lost $1.02 billion in the first six months of 2026 on just $140.6 million of revenue. Yet NVIDIA Corporation (NASDAQ:NVDA) is committing $1 billion to a $3.1 billion convertible financing, while Microsoft […]
For those hoping to get in on the autonomous ride-hailing industry, they need to consider the following things.
Iambic Therapeutics, Inc., an AI drug discovery company backed by Nvidia Corp. (NASDAQ:NVDA) and the Qatar Investment Authority, filed for an initial public offering, according to an S-1 filing with the SEC on Monday. Plans to List on Nasdaq, Under Ticker ‘IAM’ Iambic said it plans to use the IPO proceeds, along with its existing cash, to continue advancing its three cancer drug candidates through clinical development, with any remaining funds going toward general operating costs. It will go pub
Tech stock news for the week of Sept. 21.
There are some valuable lessons investors should learn before Anthropic goes public.
Westinghouse's IPO could unlock significant value for its owners.
Nscale, a cloud computing rival of CoreWeave and Nebius, has filed for an IPO. Nscale stock will trade on the NYSE.
Investors can add the fast-growing AI lab to their portfolios indirectly by picking up shares of Zoom Communications.
Until Anthropic goes public, investors won't have any great options to get exposure to the performance of its shares.
The Anthropic IPO will be delayed until November, the WSJ reported. OpenAI forecast massive negative cash flow, the FT reported.
Blockbuster IPOs rarely live up to the hype.
The market will be highly affected by this IPO, even if the stock isn't included in the index right away.
SpaceX completed the largest IPO in history in June.
Despite Nvidia's growth, the return on such a modest investment may be surprising.
AI data center provider Nscale has submitted paperwork for a New York initial public offering to fund computing infrastructure.
The AI developer is reportedly gearing up for an initial public offering this fall at a valuation near $2 trillion.
All signs seem to point to an affirmative answer to that question.
Will fears of AI crush Anthropic's IPO valuation prospects?
Actio could make Jazz's growing epilepsy franchise even stronger.
Spending from the AI giant could flow through nicely to electric power providers.
Three industrial stocks stand to gain from AI's power build-out, with no IPO allocation required to benefit from the trend.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
